How should I treat bacterial, viral, and allergic conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Conjunctivitis

For bacterial conjunctivitis, prescribe a 5-7 day course of broad-spectrum topical antibiotic (moxifloxacin 0.5% or polymyxin B/trimethoprim) three to four times daily; for viral conjunctivitis, provide only supportive care with artificial tears and cold compresses; and for allergic conjunctivitis, use topical antihistamines with mast cell-stabilizing activity such as olopatadine or ketotifen as first-line treatment. 1

Diagnostic Approach: Distinguishing the Three Types

Before treating, you must differentiate between bacterial, viral, and allergic etiologies based on specific clinical features:

Bacterial Conjunctivitis

  • Discharge character: Mucopurulent or purulent discharge with eyelids matted shut on waking is the hallmark 1, 2
  • Conjunctival reaction: Papillary rather than follicular reaction on tarsal conjunctiva 1
  • Laterality: Can be unilateral or bilateral 1
  • Associated features: May have concurrent otitis media, sinusitis, or pharyngitis, especially in children 1
  • Preauricular lymphadenopathy: Less common unless caused by hypervirulent organisms 1

Viral Conjunctivitis

  • Discharge character: Watery discharge, not purulent 1, 2
  • Conjunctival reaction: Follicular reaction on inferior tarsal conjunctiva 1, 2
  • Onset and laterality: Abrupt onset, often starts unilateral but becomes sequentially bilateral within days 1, 2
  • Associated features: Concurrent upper respiratory infection, preauricular lymphadenopathy (especially adenovirus), subconjunctival hemorrhages, chemosis, eyelid swelling 1
  • Duration: Self-limited, typically resolves within 5-14 days 1

Allergic Conjunctivitis

  • Distinguishing symptom: Itching is the most consistent and distinguishing feature 1, 2
  • Discharge: Watery with mild mucous component 1
  • Laterality: Always bilateral 1
  • Associated features: History of atopy, asthma, or eczema; concurrent allergic rhinitis; eyelid edema; periorbital hyperpigmentation 1, 2
  • Preauricular lymphadenopathy: Absent 1

Treatment Algorithm by Etiology

Bacterial Conjunctivitis Treatment

Mild to Moderate Cases:

  • Prescribe a 5-7 day course of broad-spectrum topical antibiotic 1, 3
  • No single antibiotic is superior, so choose based on convenience and cost 1, 3
  • First-line options: Moxifloxacin 0.5% three times daily, polymyxin B/trimethoprim four times daily, or erythromycin ointment 1, 3
  • Fourth-generation fluoroquinolones (moxifloxacin) provide superior gram-positive coverage including some MRSA strains 3
  • Topical antibiotics provide earlier clinical remission (68.2% cure vs 55.5% placebo by days 4-9) and allow faster return to work or school 1, 3

Important caveat: Mild bacterial conjunctivitis is self-limited in immunocompetent adults, with 64% resolving spontaneously by days 6-10 without treatment 1, 3

Severe Cases or Treatment Failure:

  • Obtain conjunctival cultures and Gram staining before initiating treatment 1, 3
  • Consider MRSA if patient is from nursing home or has community-acquired infection 3
  • MRSA isolates are generally resistant to fluoroquinolones but susceptible to vancomycin; may require compounded topical vancomycin 3
  • If no improvement after 48-72 hours, obtain cultures and consider resistant organisms 3

Special High-Risk Bacterial Forms Requiring Systemic Treatment:

Gonococcal Conjunctivitis:

  • Clinical presentation: Marked eyelid edema, severe hyperpurulent discharge, rapid progression, risk of corneal perforation 1, 2
  • Treatment: Ceftriaxone 250 mg IM single dose PLUS azithromycin 1 g oral single dose 3
  • Additional measures: Topical antibiotics, saline lavage, daily monitoring until resolution 1, 3
  • Critical: Obtain cultures and Gram stain before treatment; evaluate and treat sexual partners 1, 3

Chlamydial Conjunctivitis:

  • Treatment: Azithromycin 1 g oral single dose OR doxycycline 100 mg oral twice daily for 7 days 3
  • Rationale: Topical therapy alone is inadequate; more than 50% of infants have concurrent infection at other sites 1, 3
  • Critical: Evaluate and treat sexual partners; re-evaluate after treatment completion 1, 3

Neonatal Conjunctivitis:

  • Gonococcal: Ceftriaxone 25-50 mg/kg IV or IM single dose (max 125 mg) 3
  • Chlamydial: Erythromycin base or ethylsuccinate 50 mg/kg/day oral divided into 4 doses for 14 days 3
  • Critical: Requires hospitalization, daily ophthalmology follow-up, and evaluation for sexual abuse in older children 1, 3

Viral Conjunctivitis Treatment

Standard Management (Adenovirus):

  • Do NOT prescribe antibiotics – they provide no benefit and may cause toxicity 1, 3
  • Supportive care only: Refrigerated preservative-free artificial tears four times daily, cold compresses, topical antihistamines for symptomatic relief 1, 3
  • Patient education: Highly contagious; minimize contact with others for 10-14 days from symptom onset 1
  • Infection control: Strict hand hygiene with soap and water, avoid sharing towels/pillows, disinfect surfaces 1

Severe Adenoviral Cases (with marked chemosis, severe lid swelling, epithelial sloughing, or membranous conjunctivitis):

  • Consider topical corticosteroids (fluorometholone, rimexolone, or loteprednol) with extreme caution 1, 3
  • Mandatory monitoring: Regular IOP measurement and pupillary dilation to evaluate for cataract 1, 3
  • Re-evaluate within 1 week for severe cases 1
  • Caution: Corticosteroids may prolong viral shedding and worsen HSV infections 1, 3

Herpes Simplex Virus (HSV) Conjunctivitis:

  • Topical antivirals: Ganciclovir 0.15% gel three to five times daily OR trifluridine 1% solution five to eight times daily 3
  • Add oral antivirals: Acyclovir, valacyclovir, or famciclovir 3
  • NEVER use topical corticosteroids without antiviral coverage – they potentiate HSV infection and can cause corneal perforation 1, 3
  • Distinguishing features: Usually unilateral, vesicular rash or ulceration of eyelids, dendritic epithelial keratitis 1

Allergic Conjunctivitis Treatment

First-Line Treatment:

  • Topical antihistamines with mast cell-stabilizing activity: Olopatadine or ketotifen 1, 3
  • Environmental modifications: Wear sunglasses as allergen barrier, use cold compresses, refrigerated artificial tears, avoid eye rubbing 1

Adjunctive Measures:

  • Allergen avoidance strategies 1
  • Oral antihistamines (less effective than topical for ocular symptoms) 1

Refractory Cases:

  • Short-term topical corticosteroids: Brief 1-2 week course with low side-effect profile (fluorometholone, rimexolone, or loteprednol) 1, 3
  • Monitor: IOP and cataract formation with periodic pupillary dilation 1
  • Alternative: Cyclosporine drops 0.05% to 1% 3

Severe Cases:

  • Allergen-specific immunotherapy, more beneficial in children than adults 1
  • Multidisciplinary approach with allergists 1

Critical Red Flags Requiring Immediate Ophthalmology Referral

Refer urgently if ANY of the following are present: 1, 3

  • Visual loss or decreased vision
  • Moderate or severe pain (beyond mild irritation)
  • Severe purulent discharge (possible gonococcal infection)
  • Corneal involvement (opacity, infiltrate, ulcer, or fluorescein uptake)
  • Conjunctival scarring
  • Lack of response to therapy after 3-4 days
  • Recurrent episodes
  • History of HSV eye disease
  • Immunocompromised state
  • Recent ocular surgery
  • Vesicular rash on eyelids or nose
  • Neonatal conjunctivitis (any age <28 days)

Common Pitfalls to Avoid

  • Never use antibiotics indiscriminately for viral conjunctivitis – contributes to resistance and causes unnecessary toxicity 1, 3
  • Never use combination antibiotic-steroid drops (e.g., Tobradex) without definitively excluding viral etiology – steroids can exacerbate viral infections and prolong viral shedding 3
  • Never use topical corticosteroids in HSV conjunctivitis without antiviral coverage – potentiates infection 1, 3
  • Never prescribe oral antibiotics (e.g., Augmentin) for routine bacterial conjunctivitis – topical antibiotics achieve high tissue concentrations directly at infection site; oral antibiotics cannot reach therapeutic levels in conjunctiva 3
  • Avoid chronic use of topical vasoconstrictors – causes rebound vasodilation 3
  • Do not miss gonococcal or chlamydial conjunctivitis – requires systemic treatment and can cause corneal perforation or systemic spread 1, 3
  • Consider sexual abuse in preadolescent children with gonococcal or chlamydial conjunctivitis 3
  • Avoid contact lens wear during any form of infectious conjunctivitis 1

Follow-Up Recommendations

  • Bacterial conjunctivitis: Return if no improvement in 3-4 days 3
  • Viral conjunctivitis (severe cases): Re-evaluate within 1 week 1
  • Gonococcal conjunctivitis: Daily visits until resolution 1, 3
  • Chlamydial conjunctivitis: Re-evaluate after treatment completion 1, 3
  • Patients on topical corticosteroids: Regular IOP monitoring and periodic pupillary dilation 1, 3

References

Guideline

Clinical Presentation and Management of Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Differential Diagnosis of Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Conjunctivitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.